Edgewell Personal Care Company
NYSE:EPCHousehold & Personal Products
+$1.26 today
- Market cap
- $1.30B
- Beta
- 0.49
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.67
- Dividend yield
- 2.52%
Volume 0.50M
Average 0.79M
EPC Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Edgewell Personal Care CompanyNYSE: EPC
Depreciation & Amortization · Q2 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q2 FY2026 depreciation & amortization of $19.2M fell 11.9% year over year, behind the -0.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 9.9% from the prior quarter. Over 3 fiscal years it compounded at -0.4% a year.
Context
- Depreciation & amortization amounted to 4.0% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -11.9% toward the trailing-twelve-month pace of -0.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 88.8M USD
- Year-over-year change
- +0.9%
- 4-year CAGR
- +0.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 88.8M | +0.9% |
| FY2024 | 2024-09-30 | 88M | -3.7% |
| FY2023 | 2023-09-30 | 91.4M | +1.7% |
| FY2022 | 2022-09-30 | 89.9M | +3.2% |
| FY2021 | 2021-09-30 | 87.1M | — |
Depreciation & Amortization vs competitors
How EPC compares with its peers on the latest reported figures
- EPC's LTM Mar 2026 depreciation & amortization of $85.8M is the 4th highest of the 9 companies compared; the peer median is $47.2M.
- Its year-over-year change of -0.9% is the 6th highest of 9, against a peer median of -0.5%.
- Depreciation & amortization amounts to 4.1% of revenue for EPC, versus a peer median of 2.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $119.9M | -2.4% | +1.6% | 2.3% | |
| LTM Jun 2026 | $98.7M | -0.9% | -0.4% | 3.4% | |
| LTM Mar 2026 | $86.16M | +20.7% | -1.7% | 5.9% | |
| LTM Mar 2026 | $85.8M | -0.9% | -0.4% | 4.1% | |
| LTM Mar 2026 | $50.4M | -23.2% | -10.3% | 3.5% | |
| LTM Mar 2026 | $44M | -1.7% | +2.4% | 2.7% | |
| LTM Apr 2026 | $34.8M | +0.0% | +4.8% | 2.8% | |
| LTM Mar 2026 | $33.22M | +31.5% | +16.9% | 2.9% | |
| LTM Mar 2026 | $32.1M | +1.5% | +3.6% | 2.4% | |
| Peer median (excluding EPC) | $47.2M | -0.5% | +2.0% | 2.8% | |
Competitors are the stored peer set for EPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 2.09B | 2.17B | 2.25B | 2.25B | 2.22B |
| Cost of Revenue | 1.14B | 1.29B | 1.31B | 1.3B | 1.3B |
| Gross Profit | 951.2M | 880.5M | 940.8M | 955.7M | 924.9M |
| Gross Margin | 45.6% | 40.5% | 41.8% | 42.4% | 41.6% |
| Research & Development | 57.8M | 55.5M | 58.5M | 58.4M | 57.6M |
| Selling, General & Admin | 632.7M | 627.4M | 638.7M | 662.1M | 671.7M |
| Operating Expenses | 711.3M | 698.2M | 713.8M | 756.4M | 828.3M |
| Depreciation & Amortization | 87.1M | 89.9M | 91.4M | 88M | 88.8M |
| EBITDA | 302.1M | 285.4M | 317.6M | 285.4M | 185.6M |
| EBITDA Margin | 14.5% | 13.1% | 14.1% | 12.7% | 8.3% |
| Operating Income | 239.9M | 182.3M | 227M | 199.3M | 96.6M |
| Operating Margin | 11.5% | 8.4% | 10.1% | 8.8% | 4.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 67.9M | 71.4M | 78.5M | 76.5M | 73.2M |
| Other Income / Expenses | (92.8M) | (58.2M) | (79.3M) | (78.4M) | (73M) |
| Income Before Tax | 147.1M | 124.1M | 147.7M | 120.9M | 23.6M |
| Pre-Tax Margin | 7.0% | 5.7% | 6.6% | 5.4% | 1.1% |
| Income Tax Expense | 29.3M | 24.6M | 33M | 22.3M | (1.8M) |
| Net Income | 117.8M | 99.5M | 114.7M | 98.6M | 25.4M |
| Net Margin | 5.6% | 4.6% | 5.1% | 4.4% | 1.1% |
| EPS (Basic) | 2.15 | 1.87 | 2.24 | 1.98 | 0.53 |
| EPS (Diluted) | 2.12 | 1.86 | 2.21 | 1.97 | 0.53 |
| Weighted Avg Shares | 54.4M | 53.1M | 51.2M | 49.7M | 47.5M |
| Weighted Avg Shares (Diluted) | 55.2M | 53.6M | 51.8M | 50.1M | 47.6M |
Edgewell Personal Care Company
NYSE:EPC
Intrinsic Alpha fair value
Locked
Current Price
$28.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.